PPARG and metabolic syndrome: Describing in detail the relative contribution of all currently known PPARG transcripts—and its dominant negative isoforms—in adipogenesis, as well as in tissues and cells related to processes altered in metabolic syndrome, will provide a solid basis to rule out if, and how, they may account for metabolism-related diseases.